PLXProtalix BioTherapeutics, Inc. Common Stock

CSNYSE American, LLC (XASE)·USD

Identity

Security key: 20206
Ticker: PLX
Type: CS — Common Stock
Exchange: NYSE American, LLC(XASE)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 1996-01-02
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: PLX

Detail

Enriched 2026-08-14 20:47

Market cap: $211,097,702.04
Shares outstanding (class): 80,571,642
Shares outstanding (weighted): 80,571,642
SIC: 2836 BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Employees: 226
Location: HACKENSACK, NJ
Homepage: https://www.protalix.com
Description: Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

Market cap and share counts drift.

Funds holding this security

46 funds · 46 positions · $7.46M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
iShares Russell 2000 ETF iShares Trust	IWM	$3.64M	0.01%	1,679,440 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$1.33M	0.01%	614,345 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$399.1K	0.03%	183,926 NS	FIGI
Ultra-Small Company Market Fund Bridgeway Funds, Inc.	—	$390.6K	0.32%	180,000 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$262.1K	0.01%	120,799 NS	FIGI
WisdomTree U.S. SmallCap Fund WisdomTree Trust	EES	$173.8K	0.03%	80,084 NS	FIGI
Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST	—	$170.8K	0.00%	78,711 NS	FIGI
EQ/2000 Managed Volatility Portfolio EQ Advisors Trust	—	$163.8K	0.00%	75,469 NS	FIGI
Fidelity Small Cap Growth Index Fund Fidelity Salem Street Trust	—	$120.6K	0.01%	55,578 NS	FIGI
LVIP SSGA Small-Cap Index Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST	—	$109.4K	0.01%	50,400 NS	FIGI
Small Cap Index Fund Northern Funds	—	$85.4K	0.01%	39,351 NS	FIGI
GuideMark Small/Mid Cap Core Fund GPS Funds I	—	$72.2K	0.08%	33,278 NS	FIGI
STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOL… STATE STREET INSTITUTIONAL INVESTMENT TRUST	—	$60.5K	0.00%	27,900 NS	FIGI
MetLife Russell 2000 Index Portfolio Brighthouse Funds Trust II	—	$54.9K	0.01%	25,288 NS	FIGI
Small-Cap Index Portfolio PACIFIC SELECT FUND	—	$39.5K	0.01%	18,218 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERPLX
FIGI_COMPOSITEBBG000JW08N5
FIGI_SHARE_CLASSBBG001SBVMW4
CIK0001006281
ISINUS74365A3095
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Biotechnology
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Protalix BioTherapeutics is a biopharmaceutical company developing recombinant therapeutic proteins, fitting the biotechnology industry.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.